中国药物警戒 ›› 2014, Vol. 11 ›› Issue (1): 45-46.

• 医院药事管理与合理用药 • 上一篇    下一篇

丁二磺酸腺苷蛋氨酸与头孢哌酮舒巴坦配伍禁忌原因分析

邵云   

  1. 郑州大学第三附属医院,河南 郑州 450052
  • 收稿日期:2016-02-03 修回日期:2016-02-03 出版日期:2014-01-08 发布日期:2016-02-03
  • 作者简介:邵云,女,硕士,主管药师,临床药学。

Analysis of Imcompatibility between Ademetionine 1,4-butanedisulfonate and Cefoperazone/Sulbactam

SHAO Yun   

  1. The Third Affiliated Hospital of Zhengzhou University, Henan Zhengzhou 450052, China
  • Received:2016-02-03 Revised:2016-02-03 Online:2014-01-08 Published:2016-02-03

PDF (PC)

209

摘要： 目的探讨丁二磺酸腺苷蛋氨酸与头孢哌酮舒巴坦之间是否存在配伍禁忌,研究其发生白色絮状物的原因。方法采用对照试验,观察两药分别与酸性和碱性溶液混合后的外观变化,两药相互混合后及加入酸性和碱性溶液后的外观变化。结果两药正常配制条件下未出现肉眼可见理化反应,而加入酸性物质后,头孢哌酮舒巴坦立即析出白色沉淀,该沉淀可碱化复溶。结论正常配制下两药无沉淀产生,输液管中白色絮状物是由于未使用专用溶剂溶解丁二磺酸腺苷蛋氨酸,导致酸性条件下头孢哌酮析出沉淀,正确配制使用两药可能并无配伍禁忌。

关键词: 丁二磺酸腺苷蛋氨酸, 头孢哌酮舒巴坦, 配伍禁忌

Abstract: ObjectiveTo investigate whether ademetionine 1,4-butanedisulfonate and cefoperazone/sulbactam is imcompatible, and research how the white floccule emerged. MethodsBy controlled trial, apperance change was observed after combining each medicine with acid solution and alkaline solution, and apperance change was observed after combining the mixed liquid of two medicines with acid solution and alkaline solution. ResultsNo evident apperance change was observed by normal dispensing. cefoperazone/sulbactam solution immediately generated white precipitate after adding acid solution, and the white precipitate could be dissolved in alkaline solution. ConclusionThere was no precipitate after mixing the two medicines by normal dispensing, the reason of white precipitate was to dissolve transmetil incorrectly. The two medicines may be compatible by correct dispensing.

Key words: ademetionine 1, 4-butanedisulfonate, cefoperazone/sulbactam, imcompatibility

中图分类号: